세계의 헬스케어용 생성형 AI 시장 - 규모, 점유율, 동향 분석 보고서 : 컴포넌트별, 기능별, 최종 사용자별, 용도별, 지역별 부문 예측(2025-2033년)

Generative AI In Healthcare Market Summary

The global generative AI in healthcare market size was estimated at USD 2.17 billion in 2024 and is projected to reach USD 23.56 billion by 2033, at a CAGR of 30.1% from 2025 to 2033. Artificial intelligence (AI) is rapidly reshaping the healthcare landscape, empowering healthcare professionals with comprehensive insights to optimize patient care.

Its analytical prowess, capable of processing immense amounts of data and identifying patterns, proves invaluable in medical decision-making. Generative AI, a subset of AI, stands out for its potential to create new data and solutions, offering promise for innovative approaches to diagnostics, drug discovery, and personalized medicine. Its ability to generate medical images, design drug molecules, and tailor treatments based on individual health data makes it a powerful tool in advancing healthcare outcomes.

Generative AI is emerging as a key driver in healthcare by automating labor-intensive processes, improving clinical efficiency, and reducing physician burnout. One of the most significant applications is ambient documentation, where AI tools capture and structure physician-patient conversations in real time, minimizing administrative workload and enhancing the accuracy of medical records. For instance, in 2024, Kaiser Permanente tested ambient GenAI documentation in a 10-week pilot and, after strong results, expanded it across all eight regions, covering about 600 medical offices and 40 hospitals by 2025.

In addition, Northwestern Medicine rolled out DAX Copilot in Epic across its enterprise in August 2024, becoming an early mover in the large-scale integration of generative AI into clinical workflows. These deployments highlight a decisive shift from trials to system-wide adoption, signaling growing confidence in generative AI's ability to streamline healthcare operations and drive the growth of the generative AI in healthcare industry.

Furthermore, the integration of AI-driven documentation tools into leading EHR platforms has been a major catalyst for adoption, as it streamlines physician workflows, minimizes manual data entry, improves documentation accuracy, and reduces burnout, ultimately enabling enterprise-wide deployment of generative AI across health systems. For instance, in 2024, Microsoft (Nuance) and Epic expanded the availability of DAX Copilot, embedding generative AI directly into Epic's workflows.

More than 150 health systems were named as adopters, including large providers such as Lifespan and UNC Health. Several moved beyond pilots to enterprise deployment, with Northwestern Medicine confirming a full rollout in August 2024. Intermountain Health and Overlake Medical Center also implemented DAX Copilot during the same year. These large-scale deployments demonstrate how embedding generative AI into widely used EHRs accelerates adoption, reduces integration barriers, and reinforces the technology's potential to drive market growth.

Global Generative AI in Healthcare Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the generative AI in healthcare market report based on component, function, end use, application, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Solutions
• Service
• Function Outlook (Revenue, USD Million, 2021 - 2033)
• Virtual Nursing Assistants
• Robot-Assisted AI Surgery
• Administrative Process Optimization
• Medical Imaging Analysis
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Research
• Medical Centers
• Diagnostic Centers
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical
• System
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Component Segment
  • 1.2.2. Function Segment
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Generative AI in Healthcare Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Challenge Analysis
  • 3.2.4. Industry Opportunity Analysis
• 3.3. Generative AI in Healthcare Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Economic Landscape
    • 3.3.2.3. Social Landscape
    • 3.3.2.4. Technology Landscape
    • 3.3.2.5. Environmental Landscape
    • 3.3.2.6. Legal Landscape
• 3.4. Use Cases Analysis
• 3.5. Technology Analysis:
  • 3.5.1. Machine Learning (ML)/Deep Learning
  • 3.5.2. Natural Language Processing (NLP)
  • 3.5.3. Computer Vision-based Image Analysis

Chapter 4. Generative AI in Healthcare Market: Component Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Generative AI in Healthcare Market: Component Movement Analysis, 2024 & 2033 (USD Million)
• 4.3. Solutions
  • 4.3.1. Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Services
  • 4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Generative AI in Healthcare Market: Function Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Generative AI in Healthcare Market: Function Movement Analysis, 2024 & 2033 (USD Million)
• 5.3. Virtual Nursing Assistants
  • 5.3.1. Virtual Nursing Assistants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Robot-Assisted AI Surgery
  • 5.4.1. Robot-Assisted AI Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Administrative Process Optimization
  • 5.5.1. Administrative Process Optimization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Medical Imaging Analysis
  • 5.6.1. Medical Imaging Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Generative AI in Healthcare Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Generative AI in Healthcare Market: End Use Movement Analysis, 2024 & 2033 (USD Million)
• 6.3. Clinical Research
  • 6.3.1. Clinical Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Medical Centers
  • 6.4.1. Medical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diagnostic Centers
  • 6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Generative AI in Healthcare Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Generative AI in Healthcare Market: Application Movement Analysis, 2024 & 2033 (USD Million)
• 7.3. Clinical
  • 7.3.1. Clinical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. System
  • 7.4.1. System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Generative AI in Healthcare Market: Regional Estimates & Trend Analysis

• 8.1. Generative AI in Healthcare Market Share, By Region, 2024 & 2033 USD Million
• 8.2. North America
  • 8.2.1. North America Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.2.3. Canada
    • 8.2.3.1. Canada Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
• 8.3. Europe
  • 8.3.1. Europe Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.2. UK
    • 8.3.2.1. UK Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.3. Germany
    • 8.3.3.1. Germany Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.4. France
    • 8.3.4.1. France Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.5. Italy
    • 8.3.5.1. Italy Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.6. Spain
    • 8.3.6.1. Spain Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.7. Sweden
    • 8.3.7.1. Sweden Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.8. Denmark
    • 8.3.8.1. Denmark Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.3.9. Norway
    • 8.3.9.1. Norway Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.2. China
    • 8.4.2.1. China Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.3. Japan
    • 8.4.3.1. Japan Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.4. India
    • 8.4.4.1. India Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.5. South Korea
    • 8.4.5.1. South Korea Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.6. Australia
    • 8.4.6.1. Australia Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.4.7. Thailand
    • 8.4.7.1. Thailand Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
• 8.5. Latin America
  • 8.5.1. Latin America Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.5.3. Argentina
    • 8.5.3.1. Argentina Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
    • 8.6.1.1. (USD MILLION)
  • 8.6.2. Saudi Arabia
    • 8.6.2.1. Saudi Arabia Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.6.3. UAE
    • 8.6.3.1. UAE Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD MILLION)
  • 8.6.4. South Africa
    • 8.6.4.1. South Africa Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033
  • 8.6.5. Kuwait
    • 8.6.5.1. Kuwait Generative AI in Healthcare Market Estimates and Forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Company Market Positioning
• 9.3. Participant's Overview
• 9.4. Financial Performance
• 9.5. Product Benchmarking
• 9.6. Company Heat Map Analysis
• 9.7. Strategy Mapping
• 9.8. Company Profiles/Listing
  • 9.8.1. Google LLC
  • 9.8.2. IBM
  • 9.8.3. Johnson & Johnson
  • 9.8.4. Microsoft Corporation
  • 9.8.5. Neuralink Corporation
  • 9.8.6. NioyaTech
  • 9.8.7. OpenAI
  • 9.8.8. Oracle
  • 9.8.9. Saxon
  • 9.8.10. Syntegra
  • 9.8.11. Tencent Holdings Ltd